Aminocaproic acid and menstrual loss in women using intrauterine devices.
A controlled study of the effect of aminocaproic acid 3 g six-hourly taken by mouth during menstruation was carried out on 56 women for eight months from the time of insertion of a Lippes D intrauterine device (IUD). Thirty-five women presenting with menorrhagia in association with an IUD were also treated during three out of six consecutive menses. A highly significant reduction in menstrual loss was observed during treatment in both groups.
D000614:Aminocaproates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005342:Fibrinolysis; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D008595:Menorrhagia / Q000188:drug therapy* / Q000209:etiology; D009325:Nausea / Q000139:chemically induced
D000614:Aminocaproates